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ABSTRACT

Acetaminophen poisoning remains a leading cause of acute liver failure. Some cases may be difficult to diagnose when clinical findings are equivocal, the patient’s history is misleading or
incomplete, or the acetaminophen concentration is low or undetectable at arrival to care. We
describe a case of a medically complicated young child whose acute liver failure had two of
these features. Measurement of acetaminophen-protein adducts confirmed acetaminophen as
the primary cause of her liver failure.

Introduction
Acetaminophen (N-acetyl para-amino phenol, paracetamol or APAP) is a leading cause of acute liver
failure (ALF). In some cases, the cause of ALF may
not be clear from the patient’s history. APAP measurements obtained many hours after the last ingestion
of APAP may be negative or inconclusive in establishing a diagnosis, particularly in patients with repeated
supratherapeutic ingestions.
In therapeutic doses of acetaminophen, the primary
elimination pathways are sulfate conjugation and glucuronide conjugation. In acetaminophen poisoning, a
larger fraction of the APAP undergoes oxidation –
primarily by CYP 2E1 and CYP 1A2 – to form N-acetyl
para-amino benzoquinone imine (NAPQI) [1]. NAPQI
rapidly binds to sulfhydryl groups on cysteine.
Glutathione (GSH), a tripeptide containing cysteine,
binds and detoxifies NAPQI in a reaction that consumes
the GSH. When intracellular stores of GSH become
depleted, NAPQI covalently binds to cysteine residues
in proteins (such as hepatic enzymes) forming APAPprotein adducts [2]. This disrupts the tertiary structures
of affected proteins, denatures these proteins, and leads
to cell death. In patients with early diagnosis of APAP
poisoning, N-acetylcysteine (AcetadoteV, Cumberland
Pharmaceuticals, Nashville TN) binds and detoxifies
NAPQI to avoid acute liver injury.
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Emerging technology allows detection of APAPprotein adducts in serum with a longer detection time
than for APAP [3–5]. In patients who present with
acute liver injury (such as a person reaching care two
to three days after acute APAP overdose), the diagnosis
may be unclear if the APAP exposure history is missing or inaccurate. Measuring APAP-protein adducts
can identify whether APAP is the likely cause of the
observed liver injury. We illustrate a case of diagnostic
uncertainty about the cause of acute liver failure in a
toddler with a complicated medical history.

Case report
A 2 year-old girl came to the ED at Arkansas
Children’s Hospital when her condition worsened
with two days of lethargy, vomiting, and fever after
two weeks of apparent viral infection.
Her history included perinatal anoxic brain injury
resulting in cerebral palsy, failure to thrive (8.8 kg or
<5th percentile), recurrent ear infections, and a gastrostomy tube for feeding and medications. Her
mother reported treating her fever with “one mill”
(1 mL) of APAP elixir (160 mg/5 mL) with each dose.
Abnormal laboratory values in the ED included WBC
27.18 k/mm3 (78% neutrophils), sodium 150 mmol/L,
CO2 16 mmol/L, BUN 46 mg/dL, glucose 30 mg/dL
(1.7 mmol/L). Her urinalysis and analysis of cerebral
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Figure 1. Time course of AST, ALT, and INR (right axis) over
time in hours since ED arrival.

spinal fluid were non-diagnostic. The ED did not
order liver enzymes or coagulation studies.
Upon admission, further laboratory testing revealed
that AST and ALT were 8989 IU/L and 6338 IU/L,
respectively, with an INR of 4 (Figure 1). Her APAP
concentration was 55 mcg/mL. Repeat AST and ALT
were 5136 IU/L and 5646 IU/L.
She underwent immediate transfer to a regional pediatric liver transplant center at St. Louis Children’s Hospital,
where the ICU team consulted both gastroenterology and
toxicology. She received IV N-acetylcysteine (NAC) after
transfer in a 30 mg/mL solution with 150 mg/kg/h x 1 h
followed by 12.5 mg/kg/h. Her AST and ALT after
transfer were 1831 IU/L and 4087 IU/L with INR 2.17
(Figure 1). APAP concentration was < 5 mcg/mL, and
her total bilirubin was 0.5 mg/dL. Her plasma ammonia
concentration was 80 lmol/L (normal 5-50). Nasal swab
testing confirmed adenovirus by PCR. The gastroenterology consultants concluded that she had acute hepatitis
caused by adenovirus.
Her mother continued to insist that the APAP dose
was “one mill” (about 32 mg or about 3.6 mg/kg). The
dose stated by the mother was well below the usually
recommended dose of 10-15 mg/kg in children. The
toxicology service remained concerned for APAP toxicity, and she continued receiving IV N-acetylcysteine
until her transaminases and INR improved to AST
533 IU/L, ALT 2932 IU/L, and INR 1.49 with total bilirubin 0.6 mg/dL. Hepatic ultrasound was normal.
Organic acid screening for metabolic or mitochondrial
disorders was normal.
Rapid consultation with a research laboratory specializing in APAP protein adducts led to testing of the
original blood for APAP adducts by high performance
liquid chromatography with electrochemical detection
(HPLC-EC). Four samples all showed APAP-cysteine

Figure 2. Medicine cup with water added by the child’s
mother when asked to demonstrate 1 mL.

adduct concentrations of 11 to 12 nmol/mL. Previous
research has demonstrated the relationship between
serum adducts > 1.0 nmol/mL and ALT values above
1000 IU/L in APAP-related acute liver failure [6].
Children receiving repeated therapeutic doses of APAP
during acute illness rarely develop APAP-protein
adduct concentrations above 1 nmol/mL [7].
Subsequently, when asked to demonstrate 1 mL
with water, the mother filled a medicine cup with
7 mL (Figure 2). This volume of APAP elixir would
contain 224 mg (or about 25 mg/kg per dose).
Assuming the child received four doses per day, she
likely received approximately 100 mg/kg/d.

Discussion
This case illustrates the diagnostic uncertainty that
sometimes occurs with APAP poisoning. The mother’s firm history that she was giving “1 mL” of APAP
at a time, and the positive virology test made the
diagnosis unclear. Even with her low weight, the stated
APAP dose of approximately 32 mg or 3.6 mg/kg per
dose was inconsistent with toxicity.
The APAP-protein adducts assay conclusively confirmed the APAP was the direct cause of her liver injury.
APAP-protein adduct measurement by HPLC-EC or
LC-MS/MS remains experimental and limited to research
centers [3–7]. A rapid immunoassay is in development
and may become available for clinical use. The immunoassay shows high agreement with HPLC-EC [4].

Conclusion
The assay for APAP-protein adducts is useful in
resolving the cause of acute liver injury when the role
of APAP is unclear.
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